Literature DB >> 21420390

The signalling axis mediating neuronal apoptosis in response to [Pt(O,O'-acac)(γ-acac)(DMS)].

Antonella Muscella1, Nadia Calabriso, Carla Vetrugno, Francesco Paolo Fanizzi, Sandra Angelica De Pascali, Santo Marsigliante.   

Abstract

It was previously shown that [Pt(O,O'-acac)(γ-acac)(DMS)] induces apoptosis in various cancer cells and exerts antimetastatic responses in vitro. In rats, [Pt(O,O'-acac)(γ-acac)(DMS)] reaches the central nervous system in quantities higher than cisplatin causing less excitotoxicity. The aim of the present paper was to investigate whether [Pt(O,O'-acac)(γ-acac)(DMS)] is able to exert cytotoxic effects on SH-SY5Y human neuroblastoma cell line, and to study the intracellular transduction mechanisms underlying these effects. Here we have demonstrated that [Pt(O,O'-acac)(γ-acac)(DMS)] was more effective than cisplatin in provoking apoptosis characterized by: (a) mitochondria depolarization, (b) decrease of Bcl-2 expression and increase of BAX expressions with cytosol-to-mitochondria translocation, (c) activation of caspase-7 and -9 and (d) generation of reactive oxygen species (ROS). [Pt(O,O'-acac)(γ-acac)(DMS)] provoked the activation of the following signalling kinases that were interacting with each other: PKC-δ and -ɛ, ERK1/2, p38MAPK, JNK1/2, NF-κB, c-src and FAK. We found that ROS generated by NADPH oxidase was responsible for the [Pt(O,O'-acac)(γ-acac)(DMS)]-mediated PKC-δ and -ɛ activation and consequential phosphorylation of all MAPKs. [Pt(O,O'-acac)(γ-acac)(DMS)]-induced mitochondrial apoptosis was blocked when p38MAPK and JNK1/2 were inhibited, whilst the effects on Bax/Bcl-2 mRNA and protein levels were blocked inhibiting NF-κB. NF-κB nuclear translocation was blocked inhibiting MEK1/2 activity. In addition to the induction of apoptosis [Pt(O,O'-acac)(γ-acac)(DMS)] downregulated pro-survival pathway. Survival inhibition started from mitochondrial ROS generation which induced c-src, FAK and Akt activation. In conclusion, our results suggest that [Pt(O,O'-acac)(γ-acac)(DMS)] may be considered a promising compound for the treatment of neuroblastoma. Further studies are warranted to explore in detail the therapeutic potential of this compound.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21420390     DOI: 10.1016/j.bcp.2011.03.007

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  Antitumour and antiangiogenic activities of [Pt(O,O'-acac)(γ-acac)(DMS)] in a xenograft model of human renal cell carcinoma.

Authors:  A Muscella; C Vetrugno; F Biagioni; N Calabriso; M T Calierno; F Fornai; S A De Pascali; S Marsigliante; F P Fanizzi
Journal:  Br J Pharmacol       Date:  2016-07-22       Impact factor: 8.739

2.  Novel Platinum(II) compounds modulate insulin-degrading enzyme activity and induce cell death in neuroblastoma cells.

Authors:  Grazia R Tundo; Diego Sbardella; Sandra A De Pascali; Chiara Ciaccio; Massimo Coletta; Francesco P Fanizzi; Stefano Marini
Journal:  J Biol Inorg Chem       Date:  2014-12-02       Impact factor: 3.358

3.  In vitro anticancer activity of cis-diammineplatinum(II) complexes with β-diketonate leaving group ligands.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  J Med Chem       Date:  2012-05-18       Impact factor: 7.446

4.  Different apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary culture.

Authors:  Carla Vetrugno; Antonella Muscella; Francesco Paolo Fanizzi; Luca Giulio Cossa; Danilo Migoni; Sandra Angelica De Pascali; Santo Marsigliante
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

5.  Antitumor activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer.

Authors:  A Muscella; C Vetrugno; D Migoni; F Biagioni; F P Fanizzi; F Fornai; S A De Pascali; S Marsigliante
Journal:  Cell Death Dis       Date:  2014-01-23       Impact factor: 8.469

6.  [Pt(O,O'-acac)(γ-acac)(DMS)] alters SH-SY5Y cell migration and invasion by the inhibition of Na+/H+ exchanger isoform 1 occurring through a PKC-ε/ERK/mTOR Pathway.

Authors:  Antonella Muscella; Carla Vetrugno; Nadia Calabriso; Luca Giulio Cossa; Sandra Angelica De Pascali; Francesco Paolo Fanizzi; Santo Marsigliante
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

7.  Apoptosis by [Pt(O,O'-acac)(γ-acac)(DMS)] requires PKC-δ mediated p53 activation in malignant pleural mesothelioma.

Authors:  Antonella Muscella; Carla Vetrugno; Luca Giulio Cossa; Giovanna Antonaci; Amilcare Barca; Sandra Angelica De Pascali; Francesco Paolo Fanizzi; Santo Marsigliante
Journal:  PLoS One       Date:  2017-07-12       Impact factor: 3.240

8.  In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma.

Authors:  Antonella Muscella; Carla Vetrugno; Luca Giulio Cossa; Giovanna Antonaci; Francesco De Nuccio; Sandra Angelica De Pascali; Francesco Paolo Fanizzi; Santo Marsigliante
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

9.  [Pt(O,O'-acac)(γ-acac)(DMS)] Induces Autophagy in Caki-1 Renal Cancer Cells.

Authors:  Giovanna Antonaci; Luca Giulio Cossa; Antonella Muscella; Carla Vetrugno; Sandra Angelica De Pascali; Francesco Paolo Fanizzi; Santo Marsigliante
Journal:  Biomolecules       Date:  2019-03-06

10.  A new platinum(II) compound anticancer drug candidate with selective cytotoxicity for breast cancer cells.

Authors:  A Muscella; C Vetrugno; F P Fanizzi; C Manca; S A De Pascali; S Marsigliante
Journal:  Cell Death Dis       Date:  2013-09-12       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.